12th Injectables Summit 2022

Memo

We are excited for the return of the 12th Injectables Summit this September - the one and only peers-led community dedicated to 100+ Device Design and Development, Engineering, CMC and Quality experts from pharma and biotech. After 2 years apart, we look forward to reconnecting with industry peers face-to-face and delving into the core challenges, including: - Discover novel pipelines with complex injectable formulations- Combat increasing demand for high volume, self-administered devices- Unravel the fast-evolving regulatory landscape Packed with unmissable, technical content across 3 days, you will be joined by the likes of Pfizer, Merck, Takeda, Gilead, Biogen, Novartis and Sanofi. This summit is your unique platform to benchmark against, be inspired and learn from your fellow colleagues in thisever-evolving injectable world - and leave with actionable takeaways on integrating your drug-device development cycle to engineer a safe, reliable, self-administered injectable with speed-to-market. This is the definitive summit to support your timely parenteral drug-device launch with quality, safety and regulatory compliance in mind. Join us this September to engineer the best-in-class combination products for our patients in need! URLs:Tickets: https://go.evvnt.com/1202237-2?pid=5569 Brochure: https://go.evvnt.com/1202237-3?pid=5569  Date and Time: On Tue, Sep 20, 2022 ( 9:00 AM) - Thu, Sep 22, 2022 ( 3:30 PM) Venue details: Crowne Plaza Boston - Woburn, an IHG Hotel, 15 Middlesex Canal Park Rd, Woburn, Massachusetts, 01801, United States Prices:Pharma and Biotech - Conference + 3 Workshops: USD 4796.00,Pharma and Biotech - Conference + 2 Workshops: USD 4097.00,Pharma and Biotech - Conference + 1 Workshop: USD 3498.00,Pharma and Biotech - Conference Only: USD 2899.00,Solution Provider - Conference + 3 Workshops: USD 5696.00,Solution Provider - Conference + 2 Workshops: USD 4897.00,Solution Provider - Conference + 1 Workshop: USD 4198.00,Solution Provider - Conference Only: USD 3499.00 Speakers: Kirsten Paulson, Executive Director, Global CMC-Medical Device Lead, Pfizer, Ram Halthore, Director of Engineering, Devices and Combination Product Technology, Merck, Sriman Banerjee, Head of Packaging Development and Commercial Device Engineerin, Takeda, Marieta Duvnjak, Associate Director, Scientific Advisor in Global Analytical Research and Development, Novartis, E Guan, Head of Injection Systems, Takeda, Alexandra Benbadis, Usability Leader, Sanofi, Vahideh Ansari, Hosseinzadeh Senior Engineer, Biogen, Raihan Hossain, Director, Drug, Device and Combination Product Quality, Bill and Melinda Gates Medical Research Institute, Keith Faucher, Sr. Director Device Development and Innovation, Aura Biosciences, Guangli Hu, Principal Scientist, Device Characterization Lead, Merck, Ajit D'Souza, Director, Pharmaceutical Product Development, Kiniksa Pharmaceuticals, Cory Costantino, Design Director HFR and D, Emergo by UL, Dan Formosa, Designer, ThinkActHuman, Olivia Wong, Director, Quality, Device and Combination Products, Gilead Sciences, Marycruz Alvarez, Senior Manager, Quality Assurance, Combination Products, Gilead Sciences, David Morra, Director, Devices and Digital Health, Merck, Jason Choi, Technical Lead, Biogen, Abhishek Telang, Associate Principal Scientist, Devices and Drug-Device Combinations CMC, Merck, Rakesh Khilwani, Principal Device Development Engineer, Teva Pharmaceuticals, James Leamon, Director, Biologics Device Development, Jazz Pharmaceuticals